Literature DB >> 1525472

Protein involvement in transmembrane lipid asymmetry.

P F Devaux1.   

Abstract

Transmembrane asymmetry has been extensively studied in eukaryotic cells. It is as yet only clearly demonstrated in the plasma membrane of a few cells. Subcellular organelles have evidence of lipid asymmetry, but very little consistent quantitative data exist. Proteins involved in transmembrane passage of lipids comprise enzymes of lipid metabolism and also the so-called phospholipid flippases that are either passive or active putative lipid transporters. The aminophospholipid translocase that pumps amino-phospholipids from the outer to the inner monolayer of the plasma membrane of eukaryotes is a Mg(2+)-ATP dependent protein with a high lipid selectivity. Lipid asymmetry provides an asymmetrical environment for membrane enzymes. Thus, PS (and PE) reorientation could be a way of controlling or triggering specific enzymes. Also, the asymmetrical distribution of phospholipids most likely determines the fusion-competent membranes and/or which sides of membranes should fuse. Finally, the lipid pump as well as all enzymes responsible for the net transmembrane flux of phospholipids may provide the driving force for membrane bending, notably during the formation of endocytic vesicles. Clearly, real progress in this area will be made only if the proteins of the flippase family are purified and antibodies obtained that will permit the recognition and localization of these proteins in various cells. Also, specific inhibitors as well as mutants would allow one to infer more directly what are the real functions of these proteins. At a late stage, the protein purification will eventually permit speculation on the mechanism of action of a pump that must transport simultaneously hydrophilic and hydrophobic groups through a membrane.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1525472     DOI: 10.1146/annurev.bb.21.060192.002221

Source DB:  PubMed          Journal:  Annu Rev Biophys Biomol Struct        ISSN: 1056-8700


  41 in total

1.  Compositional genomes: prebiotic information transfer in mutually catalytic noncovalent assemblies.

Authors:  D Segré; D Ben-Eli; D Lancet
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

2.  Short-chain phosphoinositide partitioning into plasma membrane models.

Authors:  Marcus D Collins; Sharona E Gordon
Journal:  Biophys J       Date:  2013-12-03       Impact factor: 4.033

3.  Breaking up is hard to do - membrane traffic in cytokinesis.

Authors:  Rytis Prekeris; Gwyn W Gould
Journal:  J Cell Sci       Date:  2008-05-15       Impact factor: 5.285

4.  Energy of dissociation of lipid bilayer from the membrane skeleton of red blood cells.

Authors:  W C Hwang; R E Waugh
Journal:  Biophys J       Date:  1997-06       Impact factor: 4.033

5.  Conformation of a protein kinase C substrate NG(28-43), and its analog in aqueous and sodium dodecyl sulfate micelle solutions.

Authors:  D K Chang; W J Chien; A I Arunkumar
Journal:  Biophys J       Date:  1997-02       Impact factor: 4.033

6.  Strategies for labeling proteins with PARACEST agents.

Authors:  Olga Vasalatiy; Piyu Zhao; Mark Woods; Andrei Marconescu; Aminta Castillo-Muzquiz; Philip Thorpe; Garry E Kiefer; A Dean Sherry
Journal:  Bioorg Med Chem       Date:  2010-06-18       Impact factor: 3.641

7.  Mathematical modelling of lipid transbilayer movement in the human erythrocyte plasma membrane.

Authors:  M Brumen; R Heinrich; A Herrmann; P Müller
Journal:  Eur Biophys J       Date:  1993       Impact factor: 1.733

Review 8.  Phosphatidylserine targeting for diagnosis and treatment of human diseases.

Authors:  Kristof Schutters; Chris Reutelingsperger
Journal:  Apoptosis       Date:  2010-09       Impact factor: 4.677

Review 9.  Lipid-packing perturbation of model membranes by pH-responsive antimicrobial peptides.

Authors:  Dayane S Alvares; Taisa Giordano Viegas; João Ruggiero Neto
Journal:  Biophys Rev       Date:  2017-08-29

10.  Large anti-HER2/neu liposomes for potential targeted intraperitoneal therapy of micrometastatic cancer.

Authors:  Stavroula Sofou; Richard Enmon; Stig Palm; Barry Kappel; Pat Zanzonico; Michael R McDevitt; David A Scheinberg; George Sgouros
Journal:  J Liposome Res       Date:  2010-01-13       Impact factor: 3.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.